Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,262.56 89.32 0.55%
S&P 500 1,842.98 12.37 0.68%
NASDAQ 4,034.16 11.47 0.29%
Ticker Volume Price Price Delta
STOXX 50 3,091.52 -40.05 -1.28%
FTSE 100 6,541.61 -42.15 -0.64%
DAX 9,173.71 -165.46 -1.77%
Ticker Volume Price Price Delta
NIKKEI 14,364.10 367.29 2.62%
TOPIX 1,161.76 25.67 2.26%
HANG SENG 22,820.66 149.40 0.66%

Today's Research: Elan Corp. PLC, Amarin Corp. PLC, Seattle Genetics Inc., and Cubist Pharmaceuticals Inc.



Today's Research: Elan Corp. PLC, Amarin Corp. PLC, Seattle Genetics Inc., and
                         Cubist Pharmaceuticals Inc.

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

LONDON, August 8, 2013

LONDON, August 8, 2013 /PRNewswire/ --

On Wednesday, August 7, 2013, all three benchmark indexes closed lower, with
the Dow Jones Industrial Average falling 0.31%, the S&P 500 falling 0.38%, and
the NASDAQ declining 0.32%. Shares in healthcare companies also ended mostly
lower. The major movers included Elan Corp. PLC (NYSE: ELN), Amarin Corp. PLC
(NASDAQ: AMRN), Seattle Genetics Inc. (NASDAQ: SGEN), and Cubist
Pharmaceuticals Inc. (NASDAQ: CBST). AAAResearchReports.com has completed its
technical analysis on ELN, AMRN, SGEN, and CBST and these free reports are
accessible by registering at:

http://www.aaaresearchreports.com/register/  

Shares in Elan Corp. PLC ended slightly higher on Wednesday, extending their
gains from the last trading session. The company's shares ended the day 0.13%
higher at $15.74 after oscillating between $15.68 and $15.79. A total of 7.83
million shares were traded, which is below the daily average volume of 13.73
million. The stock has gained 11.55% in the last one month and 36.87% in the
last three months. Moreover, the stock is currently trading near its 52-week
high of $15.92. Sign up for free technical research on ELN at:

http://www.AAAResearchReports.com/ELN080813.pdf

Shares in Amarin Corp. PLC fell sharply on Wednesday, ending the day at $5.27,
down 2.77% from the previous closing price. The company's shares fluctuated
between $5.13 and $5.46. A total of 6.65 million shares were traded, which is
above the daily average volume of 3.68 million. The stock has lost 11.58% in
the past one month and 24.82% in the last three months. Further, Amarin
Corp.'s shares are currently trading below their 50-day and 200-day moving
averages. Be sure to read our latest technical research on AMRN by registering
at:

http://www.AAAResearchReports.com/AMRN080813.pdf

Shares in Seattle Genetics Inc. moved lower on Wednesday. The company's shares
oscillated between $41.25 and $42.68 before ending the session 1.22% lower at
$42.03. A total of 0.83 million shares were traded, which is below the daily
average volume of 1.03 million. Despite Wednesday's sharp decline, Seattle
Genetics' shares have gained 20.40% in the last one month, outperforming the
S&P 500 which has gained 3.62% during the same period. Sign up and read the
complimentary report on SGEN at:

http://www.AAAResearchReports.com/SGEN080813.pdf

Cubist Pharmaceuticals Inc.'s stock struggled on Wednesday. The company's
shares hit an intra-day low of $61.41 before finishing the day 2.30% lower at
$61.54. A total of 0.76 million shares were traded, which is below the daily
average volume of 1.12 million. Despite the recent pullbacks, the company's
shares have gained 13.71% in the last one month and are trading above their
50-day and 200-day moving averages. The free report on CBST can be downloaded
by signing up now at:

http://www.AAAResearchReports.com/CBST080813.pdf

EDITOR NOTES:

 1. This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
 2. Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
 3. This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
 4. If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
 5. For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
 6. Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

AAAresearchreports.com

SOURCE AAA Research Reports

Contact: +1(646)396-9126
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement